Telomeres Length in Israeli Fibrotic ILD Patients
- Sponsor
- Barzilai Medical Center
- Study ID
- NCT06885515
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- leukocyte telomere length (LTL) will be measured using the Telomere Restriction Fragment (TRF) Analysis method — DIAGNOSTIC_TESTPeripheral blood leukocytes telomere length will be measured both by TRF analysis and by Nanopore sequencing. Both analyses will be conducted at the laboratory of Prof. Yehuda Tzfati at the Hebrew University, which is highly experienced in the field of telomere biology and in telomere length analysis. Blood samples will be taken once from each participant. No genetic sequencing will be performed as part of this study.
Study Details
Individuals with fibrotic interstitial lung diseases (FILD) will be recruited after providing informed consent. in addition to routine data as usually collected in the clinic, blood samples will be taken for measurement of telomeres length in peripheral blood leukocytes using both the Telomere Restriction Fragment (TRF) Analysis method and Nanopore sequencing. Participants with FILD will be followed-up for 2-year after recruitment, including clinical and pulmonary function tests at-least every 6 months, or more frequently, according to the treating physician discretion.
Key Dates
- Start date
- Feb 28, 2026
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: familial pulmonary fibrosisPatients with familial pulmonary fibrosis are those with at-least one first-degree or second-degree relative with FILD
- Arm: non familial pulmonary fibrosisPatients with pulmonary fibrosis without relatives with FILD
- Arm: control10 healthy age-matched controls with no personal or family history of lung disease will be recruited as well
Primary Outcome Measure
the prevalence of short LTL among Israeli patients with familial and sporadic FILD. [ Time Frame: 1 year ]
Related Studies
- Role of Genetic Factors in the Development of Lung DiseaseRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)Recruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Explanted Lung Tissues With Pulmonary FibrosisRecruiting · University of Chicago · Chicago, Illinois
- Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis PatientsPHASE1 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts